KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Accumulated Expenses (2016 - 2025)

Acadia Pharmaceuticals has reported Accumulated Expenses over the past 16 years, most recently at $45.6 million for Q4 2025.

  • Quarterly results put Accumulated Expenses at $45.6 million for Q4 2025, up 24.7% from a year ago — trailing twelve months through Dec 2025 was $45.6 million (up 24.7% YoY), and the annual figure for FY2025 was $45.6 million, up 24.7%.
  • Accumulated Expenses for Q4 2025 was $45.6 million at Acadia Pharmaceuticals, down from $334.8 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for ACAD hit a ceiling of $334.8 million in Q3 2025 and a floor of $21.3 million in Q2 2021.
  • Median Accumulated Expenses over the past 5 years was $97.5 million (2021), compared with a mean of $137.8 million.
  • Biggest five-year swings in Accumulated Expenses: soared 1151.21% in 2024 and later crashed 90.95% in 2025.
  • Acadia Pharmaceuticals' Accumulated Expenses stood at $89.2 million in 2021, then increased by 26.56% to $112.9 million in 2022, then skyrocketed by 109.69% to $236.7 million in 2023, then crashed by 84.56% to $36.6 million in 2024, then rose by 24.7% to $45.6 million in 2025.
  • The last three reported values for Accumulated Expenses were $45.6 million (Q4 2025), $334.8 million (Q3 2025), and $28.8 million (Q2 2025) per Business Quant data.